NCT07165483 Do Increasing Preoperative Timing of Single Dexmedetomidine Dose Have an Effect on Stress Response of Laryngoscopy and Intubation?
| NCT ID | NCT07165483 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Time |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2025-09-11 |
| Primary Completion | 2026-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2025-09-11 with a primary completion date of 2026-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the effect of increasing preoperative timing of single dexmedetomidine on the stress response of laryngoscopy and intubation.
Eligibility Criteria
Inclusion Criteria: * Age from 18 to 65 years. * Both sexes. * American Society of Anesthesiology (ASA) physical status I-II. Exclusion Criteria: * Severe cardiovascular problems. * Respiratory disorders. * Diabetes. * Hypertension. * Obesity. * Allergic reaction to study drugs. * Patients on antihypertensive medication (α-methyldopa, clonidine, or other α2-adrenergic agonists) * Medications that affect heart rate (HR) or blood pressure (BP). * Pregnant. * Currently breast-feeding women. * History of sleep apnea. * Those for emergency procedures.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07165483 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Time. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07165483 currently recruiting?
Yes, NCT07165483 is actively recruiting participants. Contact the research team at mselsharkawy@med.tanta.edu.eg for enrollment information.
Where is the NCT07165483 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT07165483 clinical trial?
NCT07165483 is sponsored by Tanta University. The trial plans to enroll 45 participants.